Literature DB >> 23877372

MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1.

Jian-Qiang Xu1, Ping Liu, Ming-Jue Si, Xiao-Yi Ding.   

Abstract

Numerous studies have recently suggested that miRNAs contribute to the development of various types of human cancer as well as to their proliferation and metastasis. The aim of this study was to investigate the functional significance of miR-126 and to identify its possible target genes in osteosarcoma (OS) cells. Here, we found that expression level of miR-126 was reduced in osteosarcoma cells in comparison with the adjacent normal tissues. The enforced expression of miR-126 was able to inhibit cell proliferation in U2OS and MG63 cells, while miR-126 antisense oligonucleotides (antisense miR-126) promoted cell proliferation. At the molecular level, our results further revealed that expression of Sirt1, a member of histone deacetylase, was negatively regulated by miR-126. Therefore, the data reported here demonstrate that miR-126 is an important regulator in osteosarcoma, which will contribute to better understanding of the important misregulated miRNAs in osteosarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23877372     DOI: 10.1007/s13277-013-0974-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

Review 1.  The evolution of gene regulation by transcription factors and microRNAs.

Authors:  Kevin Chen; Nikolaus Rajewsky
Journal:  Nat Rev Genet       Date:  2007-02       Impact factor: 53.242

Review 2.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

3.  microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN.

Authors:  Jian Hua Mao; Rong Ping Zhou; Ai Fen Peng; Zhi Li Liu; Shan Hu Huang; Xin Hua Long; Yong Shu
Journal:  Oncol Lett       Date:  2012-08-16       Impact factor: 2.967

Review 4.  Osteosarcoma: Conventional treatment vs. gene therapy.

Authors:  Mei Lin Tan; Peter F M Choong; Crispin R Dass
Journal:  Cancer Biol Ther       Date:  2009-02-12       Impact factor: 4.742

Review 5.  How does SIRT1 affect metabolism, senescence and cancer?

Authors:  Christopher L Brooks; Wei Gu
Journal:  Nat Rev Cancer       Date:  2008-12-29       Impact factor: 60.716

6.  miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis.

Authors:  Yun Zhang; Pengyuan Yang; Tao Sun; Dong Li; Xin Xu; Yaocheng Rui; Chaoran Li; Mengyang Chong; Toni Ibrahim; Laura Mercatali; Dino Amadori; Xincheng Lu; Dong Xie; Qi-Jing Li; Xiao-Fan Wang
Journal:  Nat Cell Biol       Date:  2013-02-10       Impact factor: 28.824

7.  SIRT1 is significantly elevated in mouse and human prostate cancer.

Authors:  Derek M Huffman; William E Grizzle; Marcas M Bamman; Jeong-su Kim; Isam A Eltoum; Ada Elgavish; Tim R Nagy
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

8.  Mammalian SIRT1 represses forkhead transcription factors.

Authors:  Maria Carla Motta; Nullin Divecha; Madeleine Lemieux; Christopher Kamel; Delin Chen; Wei Gu; Yvette Bultsma; Michael McBurney; Leonard Guarente
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

9.  let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer.

Authors:  Edin Jusufović; Matija Rijavec; Dragan Keser; Peter Korošec; Eva Sodja; Ermina Iljazović; Zorica Radojević; Mitja Košnik
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

10.  Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.

Authors:  B Song; Y Wang; Y Xi; K Kudo; S Bruheim; G I Botchkina; E Gavin; Y Wan; A Formentini; M Kornmann; O Fodstad; J Ju
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

View more
  18 in total

1.  MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.

Authors:  Hui Li; Kun Zhang; Li-Hong Liu; Yurong Ouyang; Hong-Bin Guo; Hanchong Zhang; Jie Bu; Tao Xiao
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

2.  miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL.

Authors:  Rui Tian; Xianbiao Xie; Ju Han; Canqiao Luo; Bicheng Yong; Huizhi Peng; Jingnan Shen; Tingsheng Peng
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

Review 3.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 4.  Therapeutic applications of histone deacetylase inhibitors in sarcoma.

Authors:  Fan Tang; Edwin Choy; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Cancer Treat Rev       Date:  2017-07-06       Impact factor: 12.111

5.  MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression.

Authors:  Wenbo He; Lin Feng; Dongliang Xia; Nuan Han
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.

Authors:  Yongzheng Bao; Bin Chen; Qiang Wu; Konghe Hu; Xinhua Xi; Wengang Zhu; Xueren Zhong; Jianting Chen
Journal:  Clin Exp Med       Date:  2015-10-29       Impact factor: 3.984

7.  MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate.

Authors:  Liangdong Jiang; Aiyong He; Xiaojie He; Cheng Tao
Journal:  Oncol Lett       Date:  2015-10-09       Impact factor: 2.967

8.  MiR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.

Authors:  Enqi Li; Jinli Zhang; Tianxiang Yuan; Baotong Ma
Journal:  Tumour Biol       Date:  2014-05-07

9.  miR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9.

Authors:  Liangdong Jiang; Aiyong He; Qing Zhang; Cheng Tao
Journal:  Tumour Biol       Date:  2014-09-12

10.  MicroRNA‑20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression.

Authors:  Wenkun Zhuo; Weiming Ge; Guolin Meng; Shuaijun Jia; Xiang Zhou; Jian Liu
Journal:  Mol Med Rep       Date:  2015-07-20       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.